Glucose instability has been proposed to be one of the risk factors for diabetic complications, in particular retinopathy, since the publication of the Diabetes Control and Complication Trial (DCCT) 20 years ago. In that study, as compared with conventional therapy, intensive therapy effectively delays the onset and slows the progression of diabetic complications in patients with type 1 diabetes[1](#jdi12147-bib-0001){ref-type="ref"}. The following analyses have found that in addition to mean glycated hemoglobin (HbA~1c~) level, high HbA~1c~ variability, but not glucose variability, might be associated with increased risks of retinopathy, nephropathy and perhaps neuropathy, in type 1 diabetic patients (Table [1](#jdi12147-tbl-0001){ref-type="table-wrap"})[2](#jdi12147-bib-0002 jdi12147-bib-0003 jdi12147-bib-0004 jdi12147-bib-0005 jdi12147-bib-0006 jdi12147-bib-0007 jdi12147-bib-0008){ref-type="ref"}. Although many laboratory and clinical studies suggested that 'short‐term' glucose fluctuation, mostly driven by high postprandial blood glucose levels, leading to increased oxidative stress and decreased endothelial function, is responsible for the higher risks of microvascular and cardiovascular outcomes in type 2 diabetic patients[9](#jdi12147-bib-0009){ref-type="ref"}, the role of 'longer‐term' glucose stability in terms of HbA~1c~ variability, and the occurrence and progression of diabetic complications among type 1 diabetic patients remains elusive.

###### Studies examining the relationship between glucose or glycated hemoglobin variability and long‐term complications in type 1 diabetic patients

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year                                                Data source                         No. participants   Follow‐up duration   Variability measurement                                                                                                                                                Outcome                                                                                                               Results
  ----------------------------------------------------------- ----------------------------------- ------------------ -------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Kilpatrick, 2006[2](#jdi12147-bib-0002){ref-type="ref"}     DCCT                                1,441              5 years              Seven‐point glucose profiles were collected quarterly. The mean area under the curve and the SD of glucose variability within‐day and between visits were calculated   Retinopathy\                                                                                                          Within‐day and between‐day glucose variability does not appear to be an additional factor in the development or progression of either retinopathy nor nephropathy
                                                                                                                                                                                                                                                                                                                 \                                                                                                                     
                                                                                                                                                                                                                                                                                                                 Nephropathy                                                                                                           

  Kilpatrick, 2008[3](#jdi12147-bib-0003){ref-type="ref"}     DCCT                                1,441              NR                   HbA~1c~ was collected quarterly. The mean HbA~1c~ and the SD of HbA~1c~ variability from 6 months onwards were calculated                                              Retinopathy\                                                                                                          A~1c~ variability added to mean A~1c~ in predicting the risk of development or progression of retinopathy (HR 2.26 for every 1% increase in HbA~1c~ SD \[95% CI 1.63--3.14\]) and nephropathy (HR 1.80 \[95% CI 1.37--2.42\])
                                                                                                                                                                                                                                                                                                                 \                                                                                                                     
                                                                                                                                                                                                                                                                                                                 Nephropathy                                                                                                           

  Bragd, 2008[4](#jdi12147-bib-0004){ref-type="ref"}          Outpatient clinic at one hospital   100                11 years             SD of blood glucose was calculated based on 70 measurements over 4 weeks                                                                                               Retinopathy\                                                                                                          Glucose variability was significantly related to the presence of peripheral neuropathy (OR 2.34 \[96% CI 1.06--5.20\]), but not with incidence of proliferative retinopathy (HR 1.37 \[95% CI 0.77--2.43\]) nor nephropathy (HR 1.75 \[95% CI 0.89--3.40\])
                                                                                                                                                                                                                                                                                                                 \                                                                                                                     
                                                                                                                                                                                                                                                                                                                 Nephropathy\                                                                                                          
                                                                                                                                                                                                                                                                                                                 \                                                                                                                     
                                                                                                                                                                                                                                                                                                                 Neuropathy                                                                                                            

  Kilpatrick, 2009[5](#jdi12147-bib-0005){ref-type="ref"}     DCCT\                               1,441              NR                   Mean area under the curve glucose and the within‐day glucose variability (SD and MAGE) during the DCCT                                                                 Retinopathy\                                                                                                          Glucose variability in the DCCT did not predict the development of retinopathy or nephropathy by EDIC year 4
                                                              \                                                                                                                                                                                                                                                  \                                                                                                                     
                                                              EDIC (first 4 years)                                                                                                                                                                                                                               Nephropathy                                                                                                           

  Siegelaar, 2009[6](#jdi12147-bib-0006){ref-type="ref"}      DCCT                                1,160              5 years              Variability of blood glucose (within‐day SD) was calculated as the SD of daily blood glocose around the mean from each quarterly visit and MAGE                        Neuropathy                                                                                                            No effect of glucose variability on confirmed clinical neuropathy, autonomic neuropathy and abnormal nerve conduction

  Waden, 2009[7](#jdi12147-bib-0007){ref-type="ref"}          FinnDiane                           2,107              5.7 years            SD of all recorded A~1c~                                                                                                                                               Incident microalbuminuria, renal disease progression, cardiovascular event (MI, stroke, CABG, PTCA, limb ampuation)   SD of serial A~1c~ was independently associated with progression of renal disease (HR 1.92 \[95% CI 1.49--2.47\]) and of a cardiovascular event (HR 1.98 \[95% CI 1.39--2.82\])

  Marcovecchio, 2011[8](#jdi12147-bib-0008){ref-type="ref"}   ORPS\                               1,232              NR                   For each patient, the intrapersonal SD for annual HbA~1c~ was calculated                                                                                               Microalbuminuria development                                                                                          HbA~1c~ SD was independently associated with microalbuminuria (HR 1.31 for every 1% increase in HbA~1c~ SD \[95% CI 1.01‐1.35\])
                                                              \                                                                                                                                                                                                                                                                                                                                                                        
                                                              NFS                                                                                                                                                                                                                                                                                                                                                                      

  Hietala, 2013[10](#jdi12147-bib-0010){ref-type="ref"}       FinnDiane                           2,019              5.2 years            Coeffecient of variation (the ratio of intrapersonal SD and mean) of HbA~1c~                                                                                           Retinopathy                                                                                                           HbA~1c~ variability was associated with an increased risk of retinopathy requiring laser treatment (HR 1.60 \[95% CI 1.10--2.50\] comparing the highest with the lowest quartile)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CABG, coronary artery bypass graft surgery; CI, confidence interval; DCCT, Diabetes Control and Complication Trial; EDIC, Epidemiology of Diabetes Interventions and Complications; HbA~1c~, glycated hemoglobin; HR, hazard ratio; MAGE, mean amplitude of glycemic excursions; MI, myocardial infarction; NR, not reported; OR, odds ratio; PTCA, percutaneous transluminal coronary angioplasty; SD, standard deviation.
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In a recently published study, Hietala *et al*.[10](#jdi12147-bib-0010){ref-type="ref"} analyzed data from 2,019 type 1 diabetic patients who were enrolled in the Finnish Diabetic Nephropathy (FinnDiane) study. During the average follow up of 5.2 years, they have reconfirmed that high HbA~1c~ variability was associated with an increased risk of incidence, as well as laser treatment for retinopathy. In the earlier report, they also showed that HbA~1c~ variability was not only predictive of incident microalbuminuria and progression of renal disease, but also of incident cardiovascular events in type 1 diabetic patients[7](#jdi12147-bib-0007){ref-type="ref"}. Of note, patients with high mean HbA~1c~ values also had high HbA~1c~ variability. However, patients with low mean HbA~1c~ value, but high HbA~1c~ variability, had similar incidence for nephropathy progression as patients with high mean HbA~1c~ value, but low HbA~1c~ variability, suggesting an equally important effect of both absolute value and stability in the risk of progression in renal outcome. The significant association between HbA~1c~ variability, and risks of retinopathy and nephropathy persisted even after taking the number of HbA~1c~ measurements into consideration.

Why was HbA~1c~ instability independently associated with a higher chance of laser treatment for retinopathy? The authors emphasized that even short periods of higher HbA~1c~ could have a sustained effect on worsening of retinopathy despite subsequent improvement in glycemic control[10](#jdi12147-bib-0010){ref-type="ref"}. However, because of the inherent limitations in the observational study design, there might be other explanations for the observed association (Figure [1](#jdi12147-fig-0001){ref-type="fig"}). First, because there might be a lag time between worsening of visual symptoms and laser treatment, it is possible that diagnosis of retinopathy progression per se leads to attempts to improve glycemic control by physicians, and hence increasing HbA~1c~ fluctuation (protopathic bias or reverse causation). Second, for poorly controlled patients with high and unstable HbA~1c~ value, physicians were more likely to do fundoscopic or fundus photographic examinations, and were hence more likely to find retinopathy progression that might require laser treatment (detection bias). Third, from prior studies we knew that a variable HbA~1c~ profile is associated with several factors, such as low socioeconomic status, physical inactivity and smoking[7](#jdi12147-bib-0007){ref-type="ref"}. Perhaps, it is these lifestyle and behavior factors (including medication non‐adherence) that lead to poor outcomes.

![Possible explanations for the observed positive association between glycated hemoglobin (HbA~1c~) variability and retinopathy among type 1 diabetic patients.](jdi-5-149-g1){#jdi12147-fig-0001}

Again, we want to reassure our patients that long‐term optimal glycemic control is crucial to reduce retinopathy occurrence and its complications. For healthcare professionals who are involved in the care of diabetic patients, the findings of the study by Hietala *et al*.[10](#jdi12147-bib-0010){ref-type="ref"} highlight that patients with highly variable HbA~1c~ warrant careful monitoring of retinopathy development and progression. Further research on the mechanism of the observed association and how to prevent early retinopathy worsening for those poorly controlled type 1 patients undergoing intensive glucose lowering therapy are required to fill the knowledge gap.
